Page last updated: 2024-08-16

s-nitroso-n-acetylpenicillamine and Chronic Fatigue and Immune Dysfunction Syndrome

s-nitroso-n-acetylpenicillamine has been researched along with Chronic Fatigue and Immune Dysfunction Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Horikawa, Y; Ishikawa, J; Kanakura, Y; Kanayama, Y; Matsumura, I; Matsuzawa, Y; Nakao, H; Nishiura, T; Ogawa, M; Okajima, Y; Tomiyama, Y; Yoshida, H; Yoshimura, M1

Other Studies

1 other study(ies) available for s-nitroso-n-acetylpenicillamine and Chronic Fatigue and Immune Dysfunction Syndrome

ArticleYear
Decreased nitric oxide-mediated natural killer cell activation in chronic fatigue syndrome.
    European journal of clinical investigation, 1998, Volume: 28, Issue:11

    Topics: Adjuvants, Immunologic; Adult; Arginine; Base Sequence; Case-Control Studies; DNA Primers; Enzyme Inhibitors; Fatigue Syndrome, Chronic; Female; Humans; In Vitro Techniques; Killer Cells, Natural; Lymphocyte Subsets; Male; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Penicillamine; S-Nitroso-N-Acetylpenicillamine

1998